Postmenopausal women who consume aromatase inhibitors develops high risk for cardiova
 

Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.

More...